Fulgent Genetics Signs Lab Lease Starting At $132,071.83 A Month, Rising 3% Annually
The Needham space covers approximately 44,644 rentable square feet for diagnostic testing, research and other uses.
Fulgent Genetics, which provides laboratory testing and develops cancer treatments, signed a lease Monday starting at $132,071.83 a month in base rent, increasing 3% annually. The company described the commitment in a Wednesday SEC filing for approximately 44,644 rentable square feet in Needham, Massachusetts.
Rent Beyond The Base Payment
Fulgent leased the property at 63 Kendrick Street from EP 63 Kendrick Realty LLC, the building's landlord. The permitted uses span diagnostic testing, including anatomic pathology, as well as research, offices, warehousing and light manufacturing.
The company must pay a share of operating costs alongside base rent. It is also responsible for repairs, replacements and services inside the space and in areas reserved for its use.
Fulgent is providing a cash security deposit of $792,431, which can decline if specified conditions are met. The landlord's contribution toward improvements is capped at $100 for each rentable square foot.
Testing And Cancer Drug Development
Fulgent's laboratory business handles genetic and diagnostic tests covering rare diseases, hereditary cancer and reproductive health, alongside pathology services. It also provides testing for pharmaceutical and biotechnology companies.
Consumers can initiate testing through Picture, its telemedicine platform. The laboratory business receives payments from insurers, institutions including hospitals and government bodies, and patients paying directly.
Its therapeutic business uses a nanoencapsulation platform to develop cancer treatments. Drug candidates FID-007 and FID-022 are in clinical trials.
Fulgent operates laboratories in California, Texas, Georgia, Massachusetts and Arizona, as well as Australia. One customer generated $70.8 million of revenue in 2025, representing 22% of the company's total.
Delivery Protections And Renewal Options
The landlord's delivery target is January 1, 2027. Specified delays beyond that target entitle Fulgent to base-rent relief; a delay continuing beyond 90 days can give it a right to terminate under the lease's terms.
Fulgent estimates the lease will commence on August 1, 2027, unless final occupancy certification arrives earlier. Base-rent payments begin 180 days after commencement.
The lease expires on the final day of the month falling 126 months after commencement. Fulgent can renew for two successive five-year terms, each at fair market rent.
Sources
- 8-K Filing — Fulgent Genetics, Inc. (FLGT) — SEC EDGAR